Search Results - "Park, Daniel Youngjae"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
  2. 2

    Targeted degradation of ⍺-synuclein aggregates in Parkinson's disease using the AUTOTAC technology by Lee, Jihoon, Sung, Ki Woon, Bae, Eun-Jin, Yoon, Dabin, Kim, Dasarang, Lee, Jin Saem, Park, Da-Ha, Park, Daniel Youngjae, Mun, Su Ran, Kwon, Soon Chul, Kim, Hye Yeon, Min, Joo-Ok, Lee, Seung-Jae, Suh, Young Ho, Kwon, Yong Tae

    Published in Molecular neurodegeneration (24-06-2023)
    “…There are currently no disease-modifying therapeutics for Parkinson's disease (PD). Although extensive efforts were undertaken to develop therapeutic…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Targeted protein degradation via the autophagy-lysosome system: AUTOTAC (AUTOphagy-TArgeting Chimera) by Ji, Chang Hoon, Lee, Min Ju, Kim, Hee Yeon, Heo, Ah Jung, Park, Daniel Youngjae, Kim, Yun Kyung, Kim, Bo Yeon, Kwon, Yong Tae

    Published in Autophagy (02-09-2022)
    “…Targeted protein degradation allows targeting undruggable proteins for therapeutic applications as well as eliminating proteins of interest for research…”
    Get full text
    Journal Article
  6. 6

    Regulation of reticulophagy by the N-degron pathway by Ji, Chang Hoon, Kim, Hee Yeon, Heo, Ah Jung, Lee, Min Ju, Park, Daniel Youngjae, Kim, Dong Hyun, Kim, Bo Yeon, Kwon, Yong Tae

    Published in Autophagy (01-02-2020)
    “…Cellular homeostasis requires selective autophagic degradation of damaged or defective organelles, including the endoplasmic reticulum (ER). Previous studies…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Targeted degradation of âº-synuclein aggregates in Parkinson's disease using the AUTOTAC technology by Lee, Jihoon, Sung, Ki Woon, Bae, Eun-Jin, Yoon, Dabin, Kim, Dasarang, Lee, Jin Saem, Park, Da-ha, Park, Daniel Youngjae, Mun, Su Ran, Kwon, Soon Chul, Kim, Hye Yeon, Min, Joo-Ok, Lee, Seung-Jae, Suh, Young Ho, Kwon, Yong Tae

    Published in Molecular neurodegeneration (24-06-2023)
    “…Background There are currently no disease-modifying therapeutics for Parkinson's disease (PD). Although extensive efforts were undertaken to develop…”
    Get full text
    Journal Article